Akia is one of several patients profiled in Novartis' digital campaign to raise awareness around the rare blood disorder ITP.
July 26, 2022 02:44 PM EDTUpdated July 29, 07:23 AM
Pharma
Marketing

Eye-catch­ing pho­tos spot­light pa­tients in No­var­tis’ ITP dig­i­tal and so­cial aware­ness cam­paign

Beth Snyder Bulik

Senior Editor

Blood dis­or­der pa­tients take cen­ter­stage in No­var­tis’ aware­ness cam­paign for im­mune throm­bo­cy­tope­nia (ITP) framed in im­ages shot by an award-win­ning pho­tog­ra­ph­er and au­thor.

The ITP …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times